Good, better, best? The effects of polarization on photobiomodulation therapy by Tripodi, Nicholas et al.
R E V I EW AR T I C L E
Good, better, best? The effects of polarization on
photobiomodulation therapy
Nicholas Tripodi1,2* | Jack Feehan3,4 | Maja Husaric1,2 | Dimitrios Kiatos1,4,5 |
Fotios Sidiroglou2,6 | Sarah Fraser1 | Vasso Apostolopoulos1*
1Institute for Health and Sport, Victoria
University, Melbourne, Australia
2First Year College, Victoria University,
Melbourne, Australia
3Australian Institute for Musculoskeletal
Science (AIMSS), The University of
Melbourne and Western Health, St.
Albans, Australia
4Department of Medicine-Western Health,
Melbourne Medical School, The
University of Melbourne, St. Albans,
Australia
5College of Health and Biomedicine,
Victoria University, Melbourne, Australia
6Institute for Sustainable Industries and
Liveable Cities, Victoria University,
Melbourne, Australia
*Correspondence
Nicholas Tripodi and Vasso
Apostolopoulos, Institute for Health and
Sport, Victoria University, Melbourne,
VIC, Australia.
Email: nicholas.tripodi@vu.edu.au (N. T.)
and
Email: vasso.apostolopoulos@vu.edu.
au (V. A.)
Abstract
Photobiomodulation therapy (PBMT) is a
widely adopted form of phototherapy used
to treat many chronic conditions that
effect the population at large. The exact
physiological mechanisms of PBMT
remain unsolved; however, the prevailing
theory centres on changes in mitochon-
drial function. There are many irradiation
parameters to consider when investigating
PBMT, one of which is the state of polari-
zation. There is some evidence to show that polarization of red and near-
infrared light may promote different and/or increased biological activity when
compared to otherwise identical non-polarized light. These enhanced cellular
effects may also be present when the polarized light is applied linear to the
tissue direction. Herein, we synthesize the current experimental and clinical
evidence pertaining to polarized photobiomodulation therapy; ultimately, to
better inform future research into this area of phototherapy.
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1 | INTRODUCTION
Phototherapy encompasses a broad spectrum of thera-
peutic modalities, all designed to bring about a positive
biological effect. The earliest documented evidence of
phototherapy dates back to the ancient Egyptians, who
worshipped the sun god Ra. Through Ra's perceived
power, the worshippers would expose themselves to
direct sunlight to increase their energy levels and vitality
[1]. In more recent times, a diverse group of
phototherapeutic devices have been developed aimed at
treating of a range of conditions, spanning from skin
lesions to neurodegenerative diseases. These include: UV
therapy, commonly used to treat dermatological condi-
tions such as psoriasis, acne, vitiligo and lichen planus
[2, 3]; polarized light therapy, which is used to treat mus-
culoskeletal and dermatological conditions [4, 5]; and
broad-spectrum fluorescent light-boxes, which are used
to treat seasonal affective disorder [6–10]. Amongst all
the phototherapies used clinically, Photobiomodulation
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Therapy (PBMT), appears to be the most widely used and
accepted. PBMT is a system of phototherapy that uses
low-intensity, non-destructive laser and/or light emitting
diode (LED) to create a therapeutic effect [11]. This type
of phototherapy dates back to the 1960s, and like many
scientific breakthroughs, was discovered by mistake.
While working at Semmelwies University in Budapest,
Hungary, Endre Mester assessed whether laser could
cause cancer in mice. To his surprise, not only did the
mice exposed to lasers not develop cancer, the experi-
mental wound inflicted on them healed faster [11]. From
this point onward, the medical application of lasers and
LEDs has slowly grown, as has the evidence base [12].
PBMT has also been referred to as “cold-laser,” “soft-
laser,” “low-level laser/laser therapy” or “biostimulation”
[11, 13]. All of these use red and/or near-infrared (NIR)
light commonly to create a biological effect. The known
efficacious wavelengths that have been investigated range
between 600 nm and 1000 nm [12], thus spanning both
red and NIR. The full mechanistic effects of PBMT are
currently not clear, but its effects are known to occur at
both the cellular and molecular level [14].
PBMT has been shown to be clinically effective across
a range of pathologies, many of which cause a significant
burden to global health services and society more
broadly. Given the theorized biological effects of PBMT
on cellular factors related to tissue healing, research has
been completed that shows PBMT can accelerate the
healing of chronic diabetic ulcers [15]. PBMT has also
been shown to assist in the treatment of various dermato-
logical conditions such as psoriasis [16], hypertrophic
scars and keloids [17] and may have the capacity to mod-
ulate various acne-inducing pathways [18]. PBMT has
also been used in treating conditions associated with the
nervous system. Another key focus of clinical research
into PBMT is that of the treatment of pain. Multiple trials
have shown PBMT to be effective in promoting analgesia
in patients with diagnosed neuropathic pain [19] as well
as both chronic and acute low back and neck pain [20]
[21] [22]. Trials have also found PBMT to be of benefit in
the treatment and management of various forms of osteo-
arthritis [23, 24] and tendinopathy [25, 26]. Finally,
PBMT can also be applied to the sporting population. In
fact, PBMT can provide immediate pain relief in sports
injuries [27] and when used before exercise, can cause a
significant performance improvement in both strength
and endurance sports [28].
Despite plausible biological mechanisms and wide-
spread use, there is still more research needed to better
quantify the biological effects of PBMT and develop an
accepted set of evidence-based guidelines for its use [14].
The application of PBMT is a delicate balance; too little
energy will not create any detectible effect and too much
can cause negative effects. This is known as the biphasic
dose response or Arndt-Schulz effect [12, 13]. There can
be a number of variables manipulated that can contribute
to the summation of PBMT dosage, which include: wave-
length, irradiance, pulse structure, coherence and polari-
zation [12]. Light waves normally travel across all
different planes. Light can be polarized by blocking or
absorbing specific planes of light propagation, so the
remaining photons travel in a specified plane or planes.
There are three main types of polarization: linear polari-
zation, where light travels in a single plane only; circular
polarization, where light travels in two distinct linear
planes that are perpendicular to one another; and ellipti-
cal polarization, where the light travels in an elliptical
fashion, by combining two linear segments of light at dif-
ferent amplitudes [29]. Research suggests that linear or
circular polarization may induce different or more pro-
nounced cellular effects when compared to otherwise
identical, non-polarized light, potentially being more pro-
nounced, when polarized light aligns parallel to its target
tissue [30, 31]. Currently, there is a small amount of evi-
dence documenting the effects of polarized PBMT
(PPBMT) and fewer still comparing non-polarized PBMT
(NPPBMT) and PPBMT. Given that red and NIR light has
the largest underpinning body of evidence, it makes sense
to investigate the differences between polarized and non-
polarized light within this spectrum, before expanding to
polychromatic polarized light sources. Therefore, this
review will synthesize the current experimental and clini-
cal evidence surrounding narrow-band, monochromatic
PPBMT (600-1000 nm), ultimately to better inform this
potential area of advancement within the field of PBMT,
and help to inform other, broader-spectrum phototherapy
research.
2 | REVIEW METHODOLOGY
Searches were conducted using CINAHL (Cumulative
Index to Nursing and Allied Health Literature),
MEDLINE, PUBMED, The Cochrane Library and Google
Scholar. The following search terms were used: low-level
light therapy; photobiomodulation; photobiomodulation
therapy; low-level laser therapy; polarization; polarized
light; polarized PBMT; polarized low-level light therapy;
polarized low-level laser therapy; polarized laser; polar-
ized laser irradiation; polarized light therapy; polarized
phototherapy; polarized photobiomodulation; polarized
photobiomodulation (Figure 1). American and English
spellings were used for all terms. Studies from all years
were included. The inclusion criteria were peer reviewed
original research, reviews and case studies related to the
search topics. Studies that examined non-polarized light
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only, polychromatic light, or light outside of the 600 to
1000 nm range were omitted. Non-English articles that
were not able to be translated were excluded. Initial sea-
rch identified 7590 entries. After exclusion of duplicates
and conference abstract titles, an abstract analysis was
used to identify potential items. Full-text analysis of all
papers was performed to assess appropriateness for inclu-
sion in this review. Reference lists of included articles
were also used to locate additional relevant articles. In
total 16 number of studies were found related to red and
NIR PPBMT (Figure 1). No ethical approval was required
for this review.
3 | A PRIMER ON LIGHT-TISSUE
INTERACTIONS
Light is made up of packets of energy known as photons,
which constantly travel at the speed of light throughout
the known universe. The more photons in number, the
brighter the light is. The perceived colour of light is deter-
mined by its wavelength on the electromagnetic spec-
trum. Visible light to humans, is generally defined as a
wavelength between 400 and 700 nm. When light inter-
acts with living tissue, it can be absorbed, reflected or
transmitted [14]. Generally, only a small amount of light
is reflected from biological tissue, this is said to follow
Snell's law, which describes the change in direction of a
light wave as it transitions between two media. Most light
however, is absorbed. Light absorption by biological tis-
sue is characterised by the absorption coefficient (μa). It
is also important to consider the scattering of light within
tissue, which is the precursor to light absorption. Scatter-
ing is described by the scattering coefficient (μs). To
determine total light attenuation (μt)—the reduction in
the intensity of light due to absorption and scattering—
the scattering coefficient is added to the absorption coeffi-
cient. Hence, total light attenuation is expressed as:
μt = μs + μa:
Focussing on the components of light attenuation, an
“optical window” model has been develop to explain the
relatively high levels of light penetration of red and NIR
light [12]. As wavelengths get closer to the blue end of
the spectrum, light is absorbed and scattered more read-
ily in biological tissue. Additionally, at wavelengths
greater than 1150 nm, water starts to absorb a significant
amount of light energy. PBMT, demonstrated mainly for
wavelengths from 600 to 1000 nm, exploits this optical
range by generating maximum light penetration and
minimum light attenuation [14]. It is important to note
that this optical window refers to in vivo applications,
and may explain why otherwise wavelengths of light
show positive effects in vitro, yet do not translate to
human and animal studies. Considering polarisation in
this context, it may represent a method of achieving
improved light penetration in biological tissues within
the 600 to 1000 nm range.
4 | PBMT MECHANISMS OF
ACTION
As there is scant mechanistic evidence pertaining to
PPBMT we will prelude this review by describing the cur-
rent theoretical mechanisms of NPPBMT (Figure 2). At a
cellular level, PBMT appears to interact principally with
the mitochondria [32]. The functions of the mitochondria
are well known and are being increasingly investigated
as a source of pathology [33]. Within mammalian mito-
chondria, cytochrome c oxidase (CCO)—an enzyme of
the mitochondrial respiratory chain, which assists in the
transfer of electrons from CCO to molecular oxygen [34]
—has been shown to absorb red and NIR light, which
then affects its structure and/or function [35]. This
molecular photoacceptor is known as a chromophore
[36]. When red and NIR light interacts with the CCO
chromophore it increases its available energy and thus,
increases the mitochondrial ability to generate adenosine
triphosphate (ATP) [14]. The precise mechanism of how
PBMT affects CCO remains unknown, but the current
prevailing theory is based on the interplay between, nitric
oxide (NO), oxygen and CCO [12]. It has been shown that
NO competes with oxygen to interact with CCO,
FIGURE 1 Summary of search strategy and paper exclusion
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resulting in lowered cellular respiration and decreased
ATP production [37]. Polychromatic light has been dem-
onstrated to acutely reverse the inhibition of CCO by NO
[38]. Moreover, exogenous NO has been shown to
directly inhibit the functional cellular effects of PBMT
in vitro [39]. These processes inform this mechanistic
theory of PBMT whereby red and NIR light causes the
dissociation of NO from CCO at a mitochondrial level,
resulting in a higher rate of cellular respiration and
increased ATP production [40].
PBMT appears not only to affect mitochondrial func-
tion, it has also been shown to have an effect on cellular
reactive oxygen species (ROS) [14]. ROS are molecules
that are important in redox signalling, oxidative stress,
cell signalling, enzyme activation, regulation of cell
cycles, and protein synthesis [14, 41, 42]. During many
cellular processes, a portion of the oxygen metabolised is
converted to ROS. PBMT promotes the metabolism of
oxygen, presumably through its effects on the mitochon-
dria, which can lead to an increase ROS production [14].
This has been demonstrated in vitro with PBMT chang-
ing the redox potential of a cell toward greater oxidation
[43] and increasing ROS generation within the cell [44].
ROS can also activate nuclear factor kappa B (NF-κB)
[45]. NF-κB is a transcription factor that can activate a
number of genes, including those coded for cytokine and
chemokine release, cell adhesion, cell surface receptors,
anti-apoptosis and cellular proliferation [46, 47]. PBMT
has been shown to increase NF-κB, presumably through
the generation of ROS [45]. NF-κB is generally consid-
ered pro-inflammatory and PBMT anti-inflammatory. On
face value this does not appear to compatible, however, it
is proposed that both ROS and NF-κB may play a role in
the dose-response relationship in PBMT. In the right
amount NF-κB can cause reduced apoptosis, and
increased cell proliferation and migration—responses
thought to be beneficial in tissue healing [48]. Overexpo-
sure though, causes an undesired increase in ROS and
NF-κB, which could potentially cause the downturn in
cellular function when tissue is overexposed to PBMT
[48]. More generally ROS can cause the modulation of
DNA transcription and thus, may activate genes that play
stimulatory or protective roles within the cell [14, 42, 47].
These changes in gene expression have been demon-
strated across multiple cell lines. For example, in vitro
experiments on fibroblasts have shown that PBMT pro-
motes upregulation of multiple genes involved in DNA
repair (MPG), inflammation (LENG5), growth and prolif-
eration (CDK5R1) and metabolism (CANX) [49–51]. Sim-
ilar changes to key genes involved in adaptation and
healing have also been shown in muscle and tendon tis-
sue in vitro and in vivo [52–57]. PBMT is also thought to
play a major role in regulating the immune system by
modulating many key cells affecting the immune system.
FIGURE 2 Proposed mechanisms of PBMT diagram. PBMT, photobiomodulation therapy
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Specifically, PBMT has been shown to alter M1-related
cytokine and chemokine expression via mitochondrial
biogenesis and histone modification [58] and to enhance
proliferation of peripheral blood mononuclear cells [59].
Additionally, PBMT can cause increased macrophage
proliferation and altered differentiation [60], an increase
in CD45 lymphocytes and natural killer cells [61] and
interestingly, a decrease in the number of neutrophils in
areas of inflammation [62]. These immune changes are
key mechanisms across other forms of phototherapy [4]
and further, are fundamental in producing the pain
suppressing effects of PBMT. PBMT is known to modu-
late multiple substances related to the inflammatory
drivers of nociception, which include: Prostanoids (pros-
taglandins, leukotrienes, eicosanoids); Kinins; Serotonin;
Histamine; Cytokines; Neuropeptides; ROS; and ATP
[63]. Additionally, PBMT can decrease nociceptive input
by inhibiting A and C neural fibres by decreasing axonal
flow, thought to work in conjunction with the aforemen-
tioned molecular changes [64–66]. It is currently thought
that PPBMT works via the same pathways as NPPBMT,
however, these effects may be enhanced through polari-
zation (Figure 2).
5 | PPBMT IN VITRO
EXPERIMENTS
The effect of PPBMT has been evaluated in both connec-
tive tissue and immune cell lines with the aim of quanti-
fying PPBMT's effect on tissue healing and the immune
response. Collagen is the most abundant protein in mam-
mals and plays a critical role in the wound healing pro-
cess [67]. One study measured the effect of the
polarization angle on NIH/NT3 fibroblasts. It specifically
measured vascular endothelial growth factor (VEGF)
secretion, differentiation to myofibroblasts and collagen
organization after irradiation with a 800 nm polarized
light. Cells were irradiated at a 0, 45, 90 and 135
polarization angle for 6 minutes daily, for 6 days. This
was compared against both a population that was
exposed to light polarized in all orientations and a
non-irradiated control. The results demonstrated
increased cell viability, VEGF secretion and
myofibroblast differentiation in all irradiated groups
and compared to the non-irradiated control. In addi-
tion, the degree of polarization influenced collagen
organization. The 0 to 135 samples showed increased
collagen alignment at 30 and 130. This contrasts the
“all degree” and control sample that demonstrated
peaks at 110 and 180. However, as there was no
NPPBMT sample, this study could not demonstrate a
clear advantage of PPBMT [68].
Further, the effects of PPBMT and NPPBMT on
Wharton's jelly derived mesenchymal stem cells was
assessed. Following a 24-hour incubation period, the cells
were irradiated once for 2, 4 or 6 minutes. There was a
NPPBMT, PPBMT and control (non-irradiated) group.
Cells that were irradiated for 6 minutes showed signifi-
cantly increased levels of proliferation from the control
group, however no significant difference was observed
between the PPBMT and NPPBMT group. Furthermore,
it was clear that cell counts and colony formation were
both significantly higher after PPBMT when cells were
plated at higher confluency (500 cells, per 35 mm well).
However, scratch wound assays showed no significant
improvement in wound closure rates in any group [69]. A
limitation of this study includes that only one round of
irradiation was performed; other analogous studies have
shown that multiple doses of PLLLLT tend to show better
outcomes compared to NPPBMT [31, 70]. Nevertheless,
this study does provide evidence of some small advantage
of PPBMT over NPPBMT.
In addition, the effects of PPBMT on the immune sys-
tem have been studied. A study found that linearly
PPBMT and NPPBMT caused an immunosuppressive
effect, in terms of cellular proliferation, on human lym-
phocytes when compared to a halogen irradiated control
sample. In addition, the immunosuppressive effect of the
linear PPBMT was found to be 20% greater than the
NPPBMT sample [71]. A major limitation of this study
was a lack of exact protocol reporting, making replication
impossible.
Despite the previous experiments showing possible
advantages of PPBMT over NPPBMT there are studies
casting doubt on the increased efficacy of PPBMT over
NPPBMT. One study investigated the effects of irradiat-
ing HeLa cells with linearly polarized red laser light
(637 nm). The experiment contained four trial groups;
three groups were irradiated with a 99.4%, 60.9% and
34.2% polarization coefficient respectively, while a non-
irritated group was used as a control. Despite the number
of cells adhering to the glass surface (a measure of their
biological activity) being significantly higher in the irradi-
ated groups, there was no difference between the two
experimental groups. This led to the conclusion that
degree of polarization had no additional effects [72]. That
said, the absence of comparison to a 0% polarization and
the high exposure radiation intensity could have been
confounding factors in the study.
6 | PPBMT ANIMAL MODELS
There have been a few studies showing positive effects of
PPBMT on wound healing in animal models. One
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experiment measured the effects of PPBMT on the
healing of artificially induced wounds in mice. The mice
were irradiated with either linear or perpendicular
PPBMT (632.8 nm), with the angle of polarization being
relative to their spinal cord. Each mouse had their own
control wounds that were not irradiated. The results
demonstrated that the irradiated wounds healed faster
than the non-irradiated wounds and additionally, that
parallel polarization caused faster and more complete
healing compared to perpendicular [73]. The same
research group used a similar methodology to assess col-
lagen birefringence in skin repair in response to PPBMT
(632.8 nm). The results demonstrated that the wounds
irradiated with parallel PPBMT with respect to the rats
spinal cord showed higher birefringence, indicative of a
higher degree of collagen organisation and therefore
wound healing, when compared to perpendicular polari-
zation [74]. Researchers have also studied the differences
in light-tissue interaction between healthy and healing
rat skin. An experiment found that in the first 3 days of
healing, the polarized laser lost significantly more inten-
sity when passing through the healing tissue when com-
pared to the non-irradiated, injured control as well as
healthy tissue. The authors suggested that this effect was
possibly due to the large number of inflammatory cells
and debris in the healing tissue [75]. A similar methodol-
ogy to assess collagen birefringence in healthy rat ten-
dons. One Achilles tendon was irradiated with PPBMT
and the other no exposed to light as a control. The
PPBMT was orientated parallel relative to the tendon. It
was found that the irradiated tendon exhibited enhanced
collagen alignment relative to the control and the authors
suggested that this effect may be applicable in the treat-
ment of pathological tendons [76]. However, there was
no comparison to non-parallel PPBMT or NPPBMT and
therefore it is uncertain if the reported effects are due to
the incident polarisation or PBMT more broadly.
The effects of PPBMT on healing of rabbit tissue was
also noted. A comparison of parallel, perpendicular and
45-degree PPBMT relative to the wound against a non-
irradiated controls was assessed. It was clear that, the
fastest healing wounds were those irradiated with the
parallel polarized light, followed by the perpendicular
and 45 degree light respectively [70]. Despite positive
results, as there were only four animals examined in this
experiment, making the results less reliable - more
wound models could have been used for a stronger result.
PPBMT has also been shown to have an effect on the vis-
coelastic properties of soft tissues. A soft tissue sample
was taken from the pleura of an animal and irradiated
with PPBMT either perpendicular or parallel to the direc-
tion of tissue stretch. Tissue viscoelasticity was assessed
via displacement sensor and stretch load cell before and
after radiation. The results showed that the sample irradi-
ated parallel to the stretch direction exhibited the greatest
increase in viscoelastic capacity. The authors hypothe-
sized that this effect could be due to changes in collagen
organisation, however no direct mechanistic evidence of
this was reported, nor was the type of animal sam-
ple [77].
There has also been a combined in vivo and in vitro
study conducted on would healing in mice. Researchers
took NIH3T3 fibroblast cells from wild mice and irradi-
ated them with a 627 nm LED device at varied intensi-
ties. The experiment used five groups: an unlit control, a
non-polarized light, and three types of polarized light:
linearly polarized, right circularly polarized and left cir-
cularly polarized. In vitro, the linearly and right circu-
larly polarized group demonstrated the greatest cellular
proliferation. The authors suggested these changes were
due to an increase in the irradiation absorbance value.
The most efficacious intensity was reported to be between
2 and 8 J/cm2. In vivo, a full thickness skin defect of
20 mm in diameter was created in mice. These wounds
were irradiated using the same protocols as the in vitro
study. It was found that the linearly and right circularly
polarized light demonstrated the best healing effect at
7 days post-injury. Additionally, the right circularly
polarized light promoted significantly increased expres-
sion of the type 1 procollagen mRNA compared to the
control. However, there was no significant difference in
type 3 procollagen mRNA expression between groups
[30]. Interestingly, the authors did note a small tempera-
ture change 0.1C per/min. The authors were confident
that this small change did not influence their results,
however analysis of heat-shock proteins would have been
pertinent here to support this claim.
The effects of PPBMT on spinal cord injuries (SCI)
have also been noted. One protocol induced an artificial
spinal cord contusion using a with a weight-drop device.
Before the injury site was surgically repaired the contu-
sion was irradiated with either parallel or perpendicular
PPBMT relative to the spinal cord. These rats were com-
pared to a control group that was injured but did not
receive any irradiation. The spinal cord was re-exposed
and irradiated for five consecutive days. The results dem-
onstrated that both irradiated groups recovered faster
from the injury, with the parallel polarization group dem-
onstrating a significantly better functional evaluation
compared to the perpendicular group. Both irradiated
groups also demonstrated a significantly smaller cavity
formation induced by the contusion compared to control
and that parallel polarization caused an approximate 40%
greater light transmission through the spinal cord, com-
pared to perpendicular irradiation. Interestingly, they
also showed that there were no significant differences
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between irradiated and control groups in spinal cord ATP
content. This contradicts the key proposed mechanism of
PBMT in which it acts on mitochondrial synthesis of
ATP, implicating other biological mechanisms at play
generating a therapeutic effect. The authors hypothesized
that the improved functional recovery of the parallel irra-
diation was due to more efficient tissue light propagation
[31]. However, the light penetration was measured on a
healthy rat spinal cord, limiting its application to SCI.
Given that other research has found that light penetra-
tion through injured tissue is less than in healthy tissue
[75], the findings would be more applicable if demon-
strated on injured spinal cord tissue. All these studies
demonstrate the plausible effects of PPBMT in animal
wound healing but raise further questions about the
underpinning mechanisms of PPBMT and the optimum
dosage at different stages in healing processes.
7 | LIMITATIONS
While the research above paints a thought-provoking pic-
ture of the efficacy and mechanisms of PPBMT, there
remain many key limitations and questions. Firstly, there
are conflicting findings pertaining to the light-tissue
interactions of polarized light. Human and animal tissue
exhibits anisotropic mechanical behaviour, meaning that
their mechanical properties can vary in a three-
dimensional space throughout the body. This is thought
to be mainly due to the variation of collagen fibres in tis-
sues [78, 79]. A key limiting factor in the transmission of
light through tissues is scattering, particularly in the der-
mis due to collagen fibre density and its three-
dimensional structure [80]. One study found the orienta-
tion of polarization that causes the least light scattering
in human skin is correlated to the alignment of collagen
tissue, and may have significant implications for photo-
therapy [80]. Another study found that in denser biologi-
cal tissues, linearly polarized light is maintained better
than circularly polarized light [81]. Furthermore, it has
been shown that the more superficial layers of the skin
(epidermis, papillary dermis) allow penetration of polar-
ized light with only a small amount of depolariza-
tion [82].
There is also conflicting evidence regarding the effects
of PPBMT in vitro. One study found no change in cell
function with PPBMT and have suggested that polariza-
tion does not change the efficacy of PBMT [72]. However,
as this study used HeLa cells, which are not linearly
cylindrical structured like collagen fibres or axons, a
hypothesis might be that the morphology of a specific cell
renders them susceptible to PPBMT. Polarized light pene-
tration can also be affected by the anisotropic nature of
the skin and can be depolarized after about 1 mm [76].
However, evidence has shown that polarized light can
penetrate healthy human skin to at least 1.2 mm with
only marginal depolarization [83]. Furthermore, it has
been demonstrated in animal nerve tissue that PPBMT
applied perpendicular to the axis of the white matter
tracts caused a significant increase in light penetration
when opposed to perpendicular PPBMT [84]. In an
attempt to model in vivo circulatory conditions one study
looked at the amount of depolarization through animal
tissue with and without fluid flow through the tissue.
The results demonstrated that polarization was largely
unaffected when passing through static tissue or, when
the fluid flow was parallel to the polarization direction.
Polarization was partially lost when flow was perpendic-
ular to the polarization direction and when the rate of
fluid movement was increased [85]. Considering all this,
in conjunction with the known effects of PPBMT in ani-
mal models [31, 70] it seems plausible that polarized light
aligned parallel to cylindrical, or linear biological
microstructures such as myofibrils, axons or collagen
fibres [79] may represent a more efficacious method to
administer PBMT. With the advancement of 3D cell
culture and 3D bioprinting, the potential advantages
of PPBMT may be able to be quantified in vitro, rep-
resenting a cost saving and ethical advantage over tra-
ditional animal research. However, more in vitro
research is required to confirm this, and to reveal
whether any advantages of PPBMT found in vitro,
would persist in vivo.
Secondly, most of the experiments did not compare
PPBMT to NPPBMT and further, did not use a light con-
trol outside the 600 to 1000 nm range, only a non-
irradiation control. Therefore, it is impossible to confi-
dently state whether the reported effects of PPBMT are
significantly different from NPPBMT or even polychro-
matic, visible light sources. It is also unclear if the
reported increases in efficacy are due to the increased
penetration of PPBMT or if they are caused by the
increase in relative irradiation intensity caused by
the polarization effect. Thirdly, it remains unclear if the
plane polarized light emitted by some helium-neon
(he-ne) lasers is a factor to consider when interpreting
the findings within this field [86]. Few, if any, PBMT
research using he-ne lasers report their polarization state.
Given that there is a potential biological difference cau-
sed by this effect, any future research using he-ne lasers,
should report if they emit plane polarized light or not,
and how that light is orientated to the target tissue.
Finally, to our knowledge, there have been no human
studies conducted that compare PPBMT and NPBMT,
making clinical generalization of the relative efficacy
impossible based on the current evidence.
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8 | CONCLUSION
PBMT has been shown to be an efficacious system of
phototherapy for treating varied common conditions that
affect the population. Its proposed mechanisms are
centred on increasing available ATP and changes in gene
expression. The polarization of PBMT presents as an
interesting variable to investigate further. Some evidence
has shown when compared to NPPBMT, PPBMT can
cause quicker and more organised wound healing and
that it may be able to penetrate biological tissue more
effectively when applied in a parallel orientation relative
to the tissue being irradiated. However, more detailed
mapping of cellular and molecular responses to the ther-
apy is required to show a clear differentiation between
PPBMT and NPPBMT, and other phototherapy modali-
ties more broadly. Future research should be directed at
ascertaining more detailed mechanistic evidence in vitro
and in vivo, as well as comprehensively examining light-
tissue interactions. Overall, PPBMT appears to be a prom-
ising advancement in phototherapy, though more
research is needed to validate these claims to allow for its
clinical utilization.
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